Hypogonadism
📧 Sign up to get email alerts when something new happens for Hypogonadism.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-09-18FDA Approved: TESTOSTERONE — Original Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma, Inc.'s generic testosterone product under an Original Application (ANDA 091073). The approval enables marke…
-
CLINICAL_TRIALS withdrawal · 2017-08-24Clinical Trial Update: Sexual Dysfunction And Hypotestosteronemia In Patients With Obstructive Sleep Apnea Syndrome
A clinical trial examining sexual dysfunction and low testosterone in patients with obstructive sleep apnea was withdrawn from the registry.
-
CLINICAL_TRIALS trial_result · 2017-08-08Clinical Trial Update: Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo [Phase 2]
Phase 2 trial evaluating testosterone with anastrozole or placebo for sexual dysfunction in men with epilepsy and hypogonadism; results post…
-
FDA approval · 2017-08-07FDA Approved: TESTOSTERONE — Original Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma, Inc.'s generic testosterone product under an original ANDA (ANDA205328) for testosterone replacement. The appro…
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of testosterone gel in adult male hypogonadism has completed, with results posted in 2017…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: A Clinical Study to Evaluate the Pharmacokinetics of Testosterone Gel Using an Applicator [Phase 2]
Phase 2 pharmacokinetics study evaluating testosterone gel using an applicator in hypogonadal males has completed with results posted.
-
CLINICAL_TRIALS withdrawal · 2017-07-19Clinical Trial Update: Testosterone Therapy in Heart Failure [NA]
A clinical trial evaluating testosterone therapy for heart failure has been withdrawn. No results are reported.
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic Syndrome [Phase 3]
Phase 3 clinical trial evaluating the effects of interleukin-1 beta on low testosterone in men with obesity and metabolic syndrome; the stud…
-
FDA approval · 2017-07-12FDA Approved: TESTOSTERONE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved an original Abbreviated New Drug Application for testosterone (generic) by Padagis Israel Pharmaceuticals Ltd. This approval ma…
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With Hypogonadism [Phase 2]
Phase 2 trial evaluating follicle-stimulating hormone to improve testicular development in men with hypogonadism (including Kallmann syndrom…
-
CLINICAL_TRIALS trial_result · 2017-06-29Clinical Trial Update: Testosterone Replacement in Older Men and Atherosclerosis Progression [Phase 4]
Phase 4 clinical trial update evaluating whether testosterone replacement in older men affects progression of atherosclerosis. The results w…
-
CLINICAL_TRIALS trial_result · 2017-06-29Clinical Trial Update: Effect of Testosterone in Men With Erectile Dysfunction [Phase 4]
Phase 4 trial evaluating testosterone therapy in men with erectile dysfunction, including those with testosterone deficiency, with results p…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Effects of Testosterone Replacement on Pain Sensitivity and Pain Perception [Phase 2]
Phase 2 trial results examining whether testosterone replacement alters pain sensitivity and pain perception in men with hypogonadism.
-
FDA approval · 2017-06-16FDA Approved: TESTOSTERONE CYPIONATE — Original Application (Alvogen Inc.)
FDA approved the testosterone cypionate generic from Alvogen Inc. under Original Application (ANDA 207742).
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating how testosterone and estrogen affect the body's insulin response; the study is completed with results …
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Testosterone Replacement for Male Opioid Agonist Maintained Patients [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating testosterone replacement in men on opioid agonist therapy with chronic pain and symptomatic hypogonadism; r…
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication Administration [Phase 2]
Phase 2 clinical trial update evaluating clomiphene citrate for treating low testosterone in men on chronic opioid therapy; the study comple…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: 28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men [Phase 2]
This update reports the completion of a 28-day Phase 2 trial evaluating testosterone co-administered with dutasteride in men with hypogonadi…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Effects of TAK-448 in Middle-aged and Older Men With Low Testosterone [Phase 2]
A Phase 2 trial of TAK-448 in middle-aged and older men with low testosterone was terminated and results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Effects of Testosterone on Myocardial Repolarization [Phase 4]
A Phase 4 clinical trial assessing the effects of testosterone on myocardial repolarization has been completed in men with hypogonadism and …
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS) [Phase 2]
Phase 2 trial TERPINS evaluating testosterone replacement for nonalcoholic steatohepatitis in men with hypogonadism has completed.
-
FDA approval · 2017-03-27FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for TESTOSTERONE CYPIONATE from Padagis US LLC, indicating a modification or addition to the pre…
-
CLINICAL_TRIALS research · 2017-03-16Clinical Trial Update: Effect of 12 Weeks of Acupuncture on AMH and COH in Low Responder Patients [NA]
Clinical trial update evaluating 12 weeks of acupuncture on anti-Müllerian hormone (AMH) levels and COH response in low-responder patients w…
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men [Phase 3]
Phase 3 long-term safety study of intramuscular testosterone undecanoate in hypogonadal men has completed; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Testosterone Replacement in Men With Diabetes and Obesity [Phase 4]
Phase 4 clinical trial updates testosterone replacement in men with diabetes and obesity and hypogonadism; results posted in 2017.